Skip to main content
PMC home page
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 2005 Mar;31(3):149–152. doi: 10.1136/jme.2003.006155

Sham surgery controls are mitigated trolleys

R Albin 1
PMCID: PMC1734102  PMID: 15738434

Abstract

Debate continues about the ethics of sham surgery controls. The most powerful argument for sham surgery controls is that rigorous experiments are needed to demonstrate safety and efficacy of surgical procedures. Without such experiments, there is danger of adopting worthless procedures in clinical practice. Opponents of sham surgery controls argue that sham surgery constitutes unacceptable violation of the rights of research subjects. Recent philosophical discussion has used two thought experiments—the transplant case and the trolley problem—to explore the circumstances under which individuals may be harmed to benefit a larger group. The transplant case is felt to exemplify circumstances that forbid harming some to benefit a larger group while the trolley problem exemplifies circumstances that permit harming some to benefit others. I argue that sham surgery controls satisfy criteria derived from the trolley problem and are morally permissible.

Full Text

The Full Text of this article is available as a PDF (62.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albin R. L. Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls. J Med Ethics. 2002 Oct;28(5):322–325. doi: 10.1136/jme.28.5.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BEECHER H. K. Surgery as placebo. A quantitative study of bias. JAMA. 1961 Jul 1;176:1102–1107. doi: 10.1001/jama.1961.63040260007008. [DOI] [PubMed] [Google Scholar]
  3. COBB L. A., THOMAS G. I., DILLARD D. H., MERENDINO K. A., BRUCE R. A. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med. 1959 May 28;260(22):1115–1118. doi: 10.1056/NEJM195905282602204. [DOI] [PubMed] [Google Scholar]
  4. Clark Peter A. Placebo surgery for Parkinson's disease: do the benefits outweigh the risks? J Law Med Ethics. 2002 Spring;30(1):58–68. doi: 10.1111/j.1748-720x.2002.tb00720.x. [DOI] [PubMed] [Google Scholar]
  5. Dekkers W., Boer G. Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable? J Med Ethics. 2001 Jun;27(3):151–156. doi: 10.1136/jme.27.3.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Freed C. R., Greene P. E., Breeze R. E., Tsai W. Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J. Q. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001 Mar 8;344(10):710–719. doi: 10.1056/NEJM200103083441002. [DOI] [PubMed] [Google Scholar]
  7. Freeman T. B., Vawter D. E., Leaverton P. E., Godbold J. H., Hauser R. A., Goetz C. G., Olanow C. W. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease. N Engl J Med. 1999 Sep 23;341(13):988–992. doi: 10.1056/NEJM199909233411311. [DOI] [PubMed] [Google Scholar]
  8. Horng Sam, Miller Franklin G. Ethical framework for the use of sham procedures in clinical trials. Crit Care Med. 2003 Mar;31(3 Suppl):S126–S130. doi: 10.1097/01.CCM.0000054906.49187.67. [DOI] [PubMed] [Google Scholar]
  9. Horng Sam, Miller Franklin G. Is placebo surgery unethical? N Engl J Med. 2002 Jul 11;347(2):137–139. doi: 10.1056/NEJMsb021025. [DOI] [PubMed] [Google Scholar]
  10. Hróbjartsson A., Gøtzsche P. C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001 May 24;344(21):1594–1602. doi: 10.1056/NEJM200105243442106. [DOI] [PubMed] [Google Scholar]
  11. Joffe S., Cook E. F., Cleary P. D., Clark J. W., Weeks J. C. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet. 2001 Nov 24;358(9295):1772–1777. doi: 10.1016/S0140-6736(01)06805-2. [DOI] [PubMed] [Google Scholar]
  12. Kaptchuk T. J., Goldman P., Stone D. A., Stason W. B. Do medical devices have enhanced placebo effects? J Clin Epidemiol. 2000 Aug;53(8):786–792. doi: 10.1016/s0895-4356(00)00206-7. [DOI] [PubMed] [Google Scholar]
  13. London Alex John, Kadane Joseph B. Placebos that harm: sham surgery controls in clinical trials. Stat Methods Med Res. 2002 Oct;11(5):413–427. doi: 10.1191/0962280202sm300ra. [DOI] [PubMed] [Google Scholar]
  14. Macklin R. The ethical problems with sham surgery in clinical research. N Engl J Med. 1999 Sep 23;341(13):992–996. doi: 10.1056/NEJM199909233411312. [DOI] [PubMed] [Google Scholar]
  15. Moseley J. Bruce, O'Malley Kimberly, Petersen Nancy J., Menke Terri J., Brody Baruch A., Kuykendall David H., Hollingsworth John C., Ashton Carol M., Wray Nelda P. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002 Jul 11;347(2):81–88. doi: 10.1056/NEJMoa013259. [DOI] [PubMed] [Google Scholar]
  16. Tenery Robert, Rakatansky Herbert, Riddick Frank A., Jr, Goldrich Michael S., Morse Leonard J., O'Bannon John M., 3rd, Ray Priscilla, Smalley Sherie, Weiss Matthew, Kao Audiey. Surgical "placebo" controls. Ann Surg. 2002 Feb;235(2):303–307. doi: 10.1097/00000658-200202000-00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Weijer Charles. I need a placebo like I need a hole in the head. J Law Med Ethics. 2002 Spring;30(1):69–72. doi: 10.1111/j.1748-720x.2002.tb00721.x. [DOI] [PubMed] [Google Scholar]
  18. Yelnik J. Functional anatomy of the basal ganglia. Mov Disord. 2002;17 (Suppl 3):S15–S21. doi: 10.1002/mds.10138. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES